MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 375 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $58,757,000 | -3.2% | 1,277,879 | +1.8% | 1.30% | -4.5% |
| Q4 2015 | $60,688,000 | +13.1% | 1,255,443 | -0.5% | 1.36% | +11.7% |
| Q3 2015 | $53,640,000 | -22.9% | 1,262,107 | +107.1% | 1.21% | -18.4% |
| Q2 2015 | $69,595,000 | -6.9% | 609,417 | +5.2% | 1.49% | -15.6% |
| Q1 2015 | $74,780,000 | +36.2% | 579,372 | +5.1% | 1.76% | +20.4% |
| Q4 2014 | $54,910,000 | +27.4% | 551,251 | +26.4% | 1.46% | +12.5% |
| Q3 2014 | $43,104,000 | +95.9% | 435,970 | +52.8% | 1.30% | +92.3% |
| Q2 2014 | $21,999,000 | +33.5% | 285,407 | +11.5% | 0.68% | +16.2% |
| Q1 2014 | $16,475,000 | +6.1% | 255,938 | +5.2% | 0.58% | +0.2% |
| Q4 2013 | $15,530,000 | – | 243,333 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |